Capna IP Capital v. Helderpad — Voluntary Dismissal After 139 Days
Capna IP Capital, LLC filed a patent infringement action against Helderpad, LLC in the Western District of Washington asserting two cannabis extraction patents. The case was voluntarily dismissed without prejudice just 139 days after filing, with no defendant counsel of record appearing.
Capna IP Capital's short-lived cannabis extraction IP action in W.D. Washington
On 28 February 2023, Capna IP Capital, LLC filed a patent infringement action in the Western District of Washington (Case No. 3:23-cv-05169) before Judge Thomas S. Zilly. The defendant was Helderpad, LLC. The asserted patents — US10507407B2 and US10814248B2 — cover methods to reduce chlorophyll co-extraction in the extraction of essential oils and aromatic isolates, a technology domain directly relevant to cannabis and botanical extract processing.
The recorded basis of termination is voluntary dismissal. The docket order states that Capna IP Capital provided notice of dismissal of the action without prejudice. These are separately recorded data points; the available record does not disclose the parties' reasons for the dismissal or whether any agreement was reached between them.
The case closed on 17 July 2023 — 139 days after filing — before any defendant counsel appeared of record and before any substantive litigation milestones such as an answer, claim construction, or discovery schedule. The absence of defendant representation and the swift voluntary dismissal without prejudice may suggest the case resolved informally, but the specific terms, if any, are not disclosed in the available record.
See Complete Case & Patent Analysis →Filing to Voluntary dismissal in 139 days
139 days — faster than the median district court patent case lifecycle
US10507407B2 & US10814248B2 — cannabis extraction chlorophyll-reduction methods
Operators, equipment manufacturers, and formulators in the cannabis, hemp, and botanical extraction markets should consider a freedom-to-operate analysis against US10507407B2 and US10814248B2 — particularly those whose processes involve selective extraction of essential oils or aromatic isolates with reduced chlorophyll co-extraction. The voluntary dismissal in this case does not limit these patents' enforceability, and the plaintiff retains the right to refile.
Official order — verbatim text
The docket records Capna IP Capital's notice of voluntary dismissal without prejudice as the operative closing event. No merits ruling, claim construction, or liability finding was made. The dismissal leaves both patents fully enforceable and the plaintiff free to refile, meaning this record does not resolve the underlying infringement question for either party.
Voluntarily dismissed: what the plaintiff's notice means for both parties
Voluntary dismissal without prejudice: no merits adjudication
A plaintiff's voluntary dismissal without prejudice — filed as a notice rather than by court order — ends the current action without any ruling on the merits. Critically, it does not bar the plaintiff from refiling the same claims against the same defendant in the future, subject to applicable statutes of limitations and any applicable one-dismissal rules.
No merits rulingWith or without prejudice? What the public record says
The docket order expressly states the dismissal is without prejudice, meaning Capna IP Capital retains the right to refile patent infringement claims based on US10507407B2 and US10814248B2 against Helderpad. The recorded basis of termination is 'Voluntary dismissal' without further qualification. The specific terms underlying the dismissal, if any exist, are not disclosed in the available record.
Without prejudice — refiling possibleHelderpad faces no injunction or damages — but exposure persists
Because the dismissal is without prejudice, Helderpad, LLC obtains no res judicata protection from the dismissal. No liability finding, injunction, or damages award was entered. No defendant counsel of record appeared during the case, and no cost or fee award is recorded in the available docket. Helderpad's legal exposure under the two asserted patents remains unresolved.
No liability; exposure unresolvedAsserted patents remain live enforcement tools in cannabis extraction
US10507407B2 and US10814248B2 remain enforceable patents. The voluntary dismissal without prejudice does nothing to limit Capna IP Capital's ability to assert them against Helderpad or other parties in the cannabis and botanical extraction sector. Companies operating extraction processes that reduce chlorophyll co-extraction should treat these patents as active IP risk.
Patents remain enforceableFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Capna IP Capital, LLC | Company | /Search in Eureka ↗ |
| Defendant | Helderpad, LLC | Company | /Search in Eureka ↗ |
| Plaintiff counsel | David Allen Lowe | Attorney | Counsel for Capna IP Capital, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Lawrence D. Graham | Attorney | Counsel for Capna IP Capital, LLCSearch in Eureka ↗ |
| Plaintiff counsel | R. Scott Rhoades | Attorney | Counsel for Capna IP Capital, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Sanford E. Warren | Attorney | Counsel for Capna IP Capital, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Lowe Graham Jones, PLLC | Law Firm | Representing Capna IP Capital, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Warren Rhoades, LLP | Law Firm | Representing Capna IP Capital, LLCSearch in Eureka ↗ |
| Presiding judge | Judge Thomas S. Zilly | Judge | Washington Western District CourtSearch in Eureka ↗ |
R&D signals in cannabis and botanical extraction IP
Forward-looking patent intelligence derived from the Capna IP Capital v. Helderpad case — covering portfolio activity, extraction technology trends, and whitespace opportunities.
Capna IP Capital's extraction patent portfolio scope
As an IP holding entity, Capna IP Capital may hold patents and pending applications beyond US10507407B2 and US10814248B2. Mapping the full portfolio — including continuations under US16/023531 and US16/681765 — helps extraction operators identify the true perimeter of enforcement risk and anticipate future assertion targets.
Portfolio mappingFiling trends in chlorophyll-selective extraction technology
Selective extraction methods that suppress chlorophyll co-extraction are an active area of innovation. Tracking recent patent filings in this space — across cannabis, hemp, and broader botanical extract processing — reveals which assignees are building defensive or offensive IP positions and where the next enforcement flashpoints may emerge.
Extraction tech trendsHelderpad's IP position in botanical extraction
No defendant patent portfolio or defensive IP activity is visible from the public docket in this case. Understanding whether Helderpad holds patents in adjacent extraction technologies — or relies on third-party licensing — is relevant for assessing the balance of IP leverage in any potential refile or settlement scenario.
Defendant IP profileDesign-around and whitespace near chlorophyll-reduction patents
The claims of US10507407B2 and US10814248B2 focus on specific method steps for reducing chlorophyll during extraction. Adjacent technical approaches — such as post-extraction remediation, alternative solvent systems, or membrane filtration-based separation — may represent viable design-around or greenfield patenting opportunities for R&D teams in the extraction sector.
Design-around opportunitiesSimilar cannabis and botanical extraction patent cases in US district courts
Explore patent infringement cases involving cannabis extraction methods, essential oil processing, and plant-derived isolate patents filed in US district courts.
What this case signals for the cannabis extraction IP landscape
A swift voluntary dismissal without prejudice in a two-patent cannabis extraction case signals active portfolio monetisation activity and unresolved IP risk.
Voluntary dismissal without prejudice keeps enforcement options fully open
Capna IP Capital's decision to dismiss without prejudice preserves the right to refile. Competitors and downstream operators in cannabis and botanical extraction using chlorophyll-reduction methods should monitor Capna's filing activity and treat US10507407B2 and US10814248B2 as live litigation risks.
No defendant appearance suggests early resolution or strategic pressure
The absence of any defendant counsel on record and the case's closure in under five months is consistent with either an early informal resolution or a strategic plaintiff withdrawal. The specific driver is not disclosed in the available record, but the pattern is worth noting for entities in the extraction technology space.
Capna v Helderpad — key questions answered
Capna IP Capital asserted two patents: US10507407B2 (application US16/023531) and US10814248B2 (application US16/681765). Both cover methods to reduce chlorophyll co-extraction during the extraction of essential oils and aromatic isolates — a technology relevant to cannabis and botanical processing.
The recorded basis of termination is voluntary dismissal. The docket order states that Capna IP Capital provided notice of dismissal without prejudice. No merits ruling, liability finding, or damages award was entered. The specific terms, if any, are not disclosed in the available public record.
No. A dismissal without prejudice does not bar the plaintiff from refiling the same claims against the same or different defendants, subject to applicable statutes of limitations and procedural rules. US10507407B2 and US10814248B2 remain enforceable, and Capna IP Capital retains the right to assert them in future litigation.
No judgment, damages award, or injunction was entered against Helderpad, LLC. No defendant counsel of record appeared during the case, and the action was voluntarily dismissed before any substantive merits proceedings. No cost or fee award is recorded in the available docket.
Both patents cover methods directed at reducing chlorophyll co-extraction during the isolation of essential oils and aromatic moieties — a processing challenge particularly relevant to cannabis and hemp extraction, where chlorophyll contamination affects product colour, taste, and purity. The patents were asserted in an infringement action in the Western District of Washington.
This page is compiled from public court dockets and third-party patent and litigation data via PatSnap Eureka, and is provided for general informational purposes only. The information shown — including party names, patent and application numbers, dates, case status, outcomes, and any analysis — may be incomplete, may not reflect the most recent filings or legal status, and may contain errors or omissions. Verify all details against official court records (for example, PACER) and the relevant patent office before relying on them.
Nothing on this page constitutes legal advice or a legal opinion on the validity, infringement, enforceability, or scope of any patent or case, and no attorney‑client relationship is created by its use. Any description of an outcome (such as a dismissal, settlement, or consent judgment) is a general summary, not a legal determination. All patents, trademarks, and company or law‑firm names are the property of their respective owners. PatSnap makes no warranty as to the accuracy or completeness of this content and disclaims, to the fullest extent permitted by law, all liability for reliance on it. For advice on a specific matter, consult qualified legal counsel.
PatSnap Eureka searches patents and litigation data to answer instantly.